USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: 'parcel screening'
- Did you mean
- pace screening
- panel screening
- Related search terms
- Parcel Delivery Market
- parcel delivery thailand
- Parcel Delivery robot
- Parcel automation
- screening ad education
-
06 Nov 2019 | North America | Market Research
Growth Opportunities in Human Microbiome Market, Forecast to 2023
Strategic Collaborations and Stakeholder Awareness Along with Clear Paths to Commercialization will Play a Key Role for Success in the Human Microbiome Market
Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2022 | North America | Frost Radar
Frost Radar™: US Liquid Biopsy, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Mar 2022 | North America | Market Outlook
Next-generation Diagnostics Outlook, 2022
Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Feb 2021 | North America | Market Research
Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market
Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities
2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Aug 2021 | North America | Frost Radar
Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Feb 2021 | North America | Market Research
Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market
Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care
Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...
$2,450.00
Special Price $1,837.50 save 25 %
